<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Granulocyte transfusions from G-CSF stimulated donors were added to standard anti-infective treatment in preparation for and during allogeneic bone marrow transplantation in a young man affected by very severe <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> and invasive <z:e sem="disease" ids="C0004030" disease_type="Disease or Syndrome" abbrv="">aspergillosis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Nine concentrates with a mean neutrophil content of 18.7 x 10(9)/L (2.6 x 10(8)/kg patient b.w.) were transfused before and after marrow infusion </plain></SENT>
<SENT sid="2" pm="."><plain>An impressive clinical improvement was noticed after each granulocyte transfusion, although this was not always paralleled by a neutrophil increase in the peripheral blood </plain></SENT>
<SENT sid="3" pm="."><plain>Engraftment (N &gt; 0.5 x 10(9)/L and Plt &gt; 25 x 10(9)/L) was verified at +16 and +40 days, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>The patient is currently in complete hematological and microbiological remission 14 months after transplantation </plain></SENT>
<SENT sid="5" pm="."><plain>Granulocyte apheresis from G-CSF stimulated donors provides a high number of activated neutrophils </plain></SENT>
<SENT sid="6" pm="."><plain>At the dose given (300 micrograms/day) donor tolerance to G-CSF was excellent </plain></SENT>
<SENT sid="7" pm="."><plain>This new approach is indicated when life-threatening <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> develop in patients exposed to prolonged severe <z:hpo ids='HP_0001875'>neutropenia</z:hpo> </plain></SENT>
</text></document>